PATENT CLAIM ANALYSIS

Application Number: 16012992
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "001890"]

Abstract:
Described are assay methods, modules and kits useful in the detection, treatment and/or prevention of dementia and related conditions, including but not limited to Alzheimer's disease and mild cognitive disorders.

Claim (Index 4):
The method of  claim 2  wherein said at least one additional biomarker comprises A\u03b2 42, A\u03b2 40, A\u03b2 38, A\u03b2 39, A\u03b2 37, A\u03b2 34, A\u03b2 43, total tau, P-tau, C-tau, or combinations thereof.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12867479', '12799484', '13874052', '14200020', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7077737526489198
- 35 USC 102 Novelty (BERT): 0.5217306756849047
- Combined Prediction Score: 0.6891694449525184
- Mean Citation Score: 253.80111
- Max Citation Score: 263.87994
- Similarity Product: 160.68525901721475

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test